Literature DB >> 10980203

Activation of the Ikappa B kinases by RIP via IKKgamma /NEMO-mediated oligomerization.

J L Poyet1, S M Srinivasula, J H Lin, T Fernandes-Alnemri, S Yamaoka, P N Tsichlis, E S Alnemri.   

Abstract

To understand the mechanism of activation of the IkappaB kinase (IKK) complex in the tumor necrosis factor (TNF) receptor 1 pathway, we examined the possibility that oligomerization of the IKK complex triggered by ligand-induced trimerization of the TNF receptor 1 complex is responsible for activation of the IKKs. Gel filtration analysis of the IKK complex revealed that TNFalpha stimulation induces a large increase in the size of this complex, suggesting oligomerization. Substitution of the C-terminal region of IKKgamma, which interacts with RIP, with a truncated DR4 lacking its cytoplasmic death domain, produced a molecule that could induce IKK and NF-kappaB activation in cells in response to TRAIL. Enforced oligomerization of the N terminus of IKKgamma or truncated IKKalpha or IKKbeta lacking their serine-cluster domains can also induce IKK and NF-kappaB activation. These data suggest that IKKgamma functions as a signaling adaptor between the upstream regulators such as RIP and the IKKs and that oligomerization of the IKK complex by upstream regulators is a critical step in activation of this complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10980203     DOI: 10.1074/jbc.M006643200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Activation of the immune system by bacterial CpG-DNA.

Authors:  Georg Häcker; Vanessa Redecke; Hans Häcker
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

Review 2.  CARD games in apoptosis and immunity.

Authors:  Lisa Bouchier-Hayes; Seamus J Martin
Journal:  EMBO Rep       Date:  2002-07       Impact factor: 8.807

Review 3.  Nuclear factor (NF)-kappaB proteins: therapeutic targets.

Authors:  I M Verma
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

4.  Dichotomous actions of NF-kappaB signaling pathways in heart.

Authors:  Rimpy Dhingra; James A Shaw; Yaron Aviv; Lorrie A Kirshenbaum
Journal:  J Cardiovasc Transl Res       Date:  2010-05-25       Impact factor: 4.132

Review 5.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

6.  High-affinity interaction between IKKbeta and NEMO.

Authors:  Yu-Chih Lo; Upendra Maddineni; Jee Y Chung; Rebecca L Rich; David G Myszka; Hao Wu
Journal:  Biochemistry       Date:  2008-02-12       Impact factor: 3.162

7.  Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.

Authors:  Marianna Penzo; Paul E Massa; Eleonora Olivotto; Francesca Bianchi; Rosa Maria Borzi; Adedayo Hanidu; Xiang Li; Jun Li; Kenneth B Marcu
Journal:  J Cell Physiol       Date:  2009-01       Impact factor: 6.384

8.  High throughput short interfering RNA (siRNA) screening of the human kinome identifies novel kinases controlling the canonical nuclear factor-κB (NF-κB) activation pathway.

Authors:  Sanjeev Choudhary; Kevin P Rosenblatt; Ling Fang; Bing Tian; Zhao-Hui Wu; Allan R Brasier
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

9.  Inhibition of NF-kappaB activation with designed ankyrin-repeat proteins targeting the ubiquitin-binding/oligomerization domain of NEMO.

Authors:  Emanuel Wyler; Monika Kaminska; Yves-Marie Coïc; Françoise Baleux; Michel Véron; Fabrice Agou
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

10.  The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKgamma to block activation of the transcription factor NF-kappaB and potentiate apoptosis.

Authors:  Wei-Kuang Liu; Pei-Fen Yen; Chia-Yi Chien; Ming-Ji Fann; Jin-Yuan Su; Chen-Kung Chou
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.